Literature DB >> 16766259

Mismatch repair proteins as sensors of alkylation DNA damage.

Jean Y J Wang1, Winfried Edelmann.   

Abstract

The DNA mismatch repair (MMR) system maintains genome integrity by correcting replication errors. MMR also stimulates checkpoint and cell death responses to DNA damage suggested by the resistance of MMR-defective tumor cells to several chemotherapeutic agents. MMR-dependent cytotoxic response may result from futile repair; however, MMR-mediated apoptosis has been genetically separated from its repair function. In a recent issue of Molecular Cell, Yoshioka and coworkers show that MMR complexes (MutSalpha and MutLalpha) are required for the recruitment of ATR-ATRIP to sites of alkylation damage, demonstrating that MMR complexes can function as sensors in DNA damage signal transduction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766259     DOI: 10.1016/j.ccr.2006.05.013

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  31 in total

1.  PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors.

Authors:  Brian McEllin; Cristel V Camacho; Bipasha Mukherjee; Brandon Hahm; Nozomi Tomimatsu; Robert M Bachoo; Sandeep Burma
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis.

Authors:  Navjotsingh Pabla; Zhengwei Ma; Michael A McIlhatton; Richard Fishel; Zheng Dong
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

3.  Involvement of deoxycytidylate deaminase in the response to S(n)1-type methylation DNA damage in budding yeast.

Authors:  R Michael Liskay; Linda J Wheeler; Christopher K Mathews; Naz Erdeniz
Journal:  Curr Biol       Date:  2007-09-04       Impact factor: 10.834

4.  FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.

Authors:  Nu Zhang; Xinjian Wu; Lixuan Yang; Feizhe Xiao; Heng Zhang; Aidong Zhou; Zhengsong Huang; Suyun Huang
Journal:  Clin Cancer Res       Date:  2012-09-12       Impact factor: 12.531

5.  Genome-wide single-cell analysis of recombination activity and de novo mutation rates in human sperm.

Authors:  Jianbin Wang; H Christina Fan; Barry Behr; Stephen R Quake
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

6.  Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.

Authors:  Akshada Sawant; Anbarasi Kothandapani; Anatoly Zhitkovich; Robert W Sobol; Steve M Patrick
Journal:  DNA Repair (Amst)       Date:  2015-10-23

Review 7.  DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets.

Authors:  Long Shan Li; Julio C Morales; Martina Veigl; David Sedwick; Sheldon Greer; Mark Meyers; Mark Wagner; Richard Fishel; David A Boothman
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

8.  Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA.

Authors:  Jin-Chul Heo; Tae-Hoon Jung; Sungjin Lee; Hyun Young Kim; Gildon Choi; Myungeun Jung; Daeyoung Jung; Heung Kyoung Lee; Jung-Ok Lee; Ji-Hwan Park; Daehee Hwang; Ho Jun Seol; Heeyeong Cho
Journal:  Clin Exp Metastasis       Date:  2016-03-08       Impact factor: 5.150

9.  Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.

Authors:  Eugene Izumchenko; John Saydi; Kevin D Brown
Journal:  DNA Repair (Amst)       Date:  2012-10-11

10.  Embryonic lethality after combined inactivation of Fancd2 and Mlh1 in mice.

Authors:  Henri J van de Vrugt; Laura Eaton; Amy Hanlon Newell; Mushen Al-Dhalimy; R Michael Liskay; Susan B Olson; Markus Grompe
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.